Sylvia Singer
UCSF Benioff Children's Hospital at Oakland
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sylvia Singer as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:57 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04432623 · The BENeFiTS Trial in Beta Thalassemia IntermediaPhoenicia BioScience · enrolling by invitation · Beta Thalassemia Intermedia, Sickle Cell Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Development of a Clinical Hemoglobin ModulatorR33HL147845 · NHLBI · PHOENICIA BIOSCIENCES, INC. · fiscal years 2020 to 2022 · $1,630,002 awarded in 2022Grant number is on one of their registry trials
- Pulmonary Hypertension in ThalassemiaK23HL077409 · NHLBI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · fiscal years 2005 to 2009 · $144,531 awarded in 2009Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:57 UTC. The ranking covers the 200 most relevant of 81 PubMed records, and a shared surname and initials can bring in a namesake. All 81 on PubMed
- Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.N Engl J Med · 20023,446 citationsRCR 67.3
- Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.J Clin Oncol · 20031,807 citationsRCR 34.5
- F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients.Eur J Nucl Med Mol Imaging · 2017483 citationsRCR 19.8
- Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.Proc Natl Acad Sci U S A · 1998447 citationsRCR 8.4
- Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma.Proc Natl Acad Sci U S A · 1999443 citationsRCR 9.5
- MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study.Radiology · 2001430 citationsRCR 14.5
- Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.J Clin Oncol · 2013352 citationsRCR 9.1
- 279 citationsRCR 7.9
- 235 citationsRCR 4.0
- 167 citationsRCR 6.1